Skip to content

Mineral Bone Disorder in Dialysis

Mineral and Bone Disorder in Chronic Kidney Disease: A Comparative Analysis of Hemodialysis and Peritoneal Dialysis Modalities

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07212972
Acronym
MBDialysis
Enrollment
167
Registered
2025-10-08
Start date
2019-09-25
Completion date
2020-06-20
Last updated
2025-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease-Mineral and Bone Disorder, Chronic Kidney Failure, Dialysis, Hemodialysis

Brief summary

This study was conducted with 167 dialysis patients at Erciyes University Faculty of Medicine, Department of Internal Medicine, Department of Nephrology, and Dialysis Unit, with the approval of the Ethics Committee of Erciyes University Medical Faculty (date: 25.09.2019, no: 2019/673). Patients aged ≥18 years, undergoing dialysis treatment, and having available data on serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium levels within the last six months were included in the study.

Interventions

OTHERHemodialysis or peritoneal Dialysis

Hemodialysis or peritoneal Dialysis

Sponsors

Çanakkale Onsekiz Mart University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years, * Diagnosed with chronic kidney disease (CKD) and undergoing dialysis treatment (hemodialysis or peritoneal dialysis) * Availability of laboratory results within the last 6 months: serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium * Patient consent to participate

Exclusion criteria

* Age \< 18 years * Patients not on dialysis treatment * Missing or incomplete laboratory data * History of malignancy, acute infection, or other systemic diseases interfering with mineral and bone metabolism * Patients who did not provide consent or could not complete the questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Blood valuesAt the enrollmentSerum levels of calcium, phosphorus, parathyroid hormone, albumin, hemoglobin, BUN, creatinine, and dialysate calcium

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026